|
|
|||
|
||||
OverviewThe integration of nanoparticles with classical drugs to create biocompatible delivery platforms for the treatment of cardiovascular diseases can make a major impact on patient welfare. Traditional drug delivery systems are not selective and induce severe collateral damage to surrounding non-diseased cells and tissues. Nanoparticles, however, can be bio-conjugated with antibodies to encapsulate cardiovascular drugs, gaseous molecules and biomolecules to selectively deliver them in a safe, targeted and cost-effective manner. This book provides in-depth and insightful discussion on the mechanistic, pre-clinical and clinical applications of nanomedicine in cardiovascular disease. It not only discusses core chemical concepts via the synthesis of novel nanotechnology-based drug formulations, but also covers the latest drug delivery advances including innovative therapeutic targets in cardiovascular lesions at an early, curable and reversible stage. Written by experts in the field, students and researchers will find this book equally useful for understanding the trends and challenges of the clinical translation of cardiovascular nanomedicine. Full Product DetailsAuthor: Roger Narayan (University of North Carolina, USA) , Tanveer Tabish (University of Oxford, UK)Publisher: Royal Society of Chemistry Imprint: Royal Society of Chemistry Volume: Volume 64 Dimensions: Width: 15.60cm , Height: 1.70cm , Length: 23.40cm Weight: 0.575kg ISBN: 9781837670581ISBN 10: 1837670587 Pages: 278 Publication Date: 25 October 2024 Audience: Professional and scholarly , Professional & Vocational Format: Hardback Publisher's Status: Active Availability: Temporarily unavailable The supplier advises that this item is temporarily unavailable. It will be ordered for you and placed on backorder. Once it does come back in stock, we will ship it out to you. Table of ContentsCardiovascular Nanomedicine: From Targeted Delivery to Theranostics;Photoluminescent Nanomaterials for Cardiovascular Diagnosis and Therapeutics;Nanoparticles for the Treatment of Ischemic Heart Diseases;Cardiovascular Nanomedicine: Mode of Action and Applications;Novel Nanotherapies for the Treatment of Coronary Atherosclerosis;Advanced Nanomaterials for Cardiovascular Implants;Bio Ceramics Based Cardiovascular Implants;Targeted Gold Nanotherapy for the Attenuation of Chemotherapy-associated Cardiotoxicity;Extracellular Vesicles for the Treatment of Cardiovascular DiseasesReviewsAuthor InformationTab Content 6Author Website:Countries AvailableAll regions |